Found: 76
Select item for more details and to access through your institution.
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 9, p. 3063, doi. 10.1172/JCI62636
- By:
- Publication type:
- Article
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients—A Randomized Phase 2 Clinical Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3682, doi. 10.3390/jcm9113682
- By:
- Publication type:
- Article
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 1, p. 51, doi. 10.1038/nbt.3051
- By:
- Publication type:
- Article
Identification of gene fusions associated with amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2024, v. 69, n. 4, p. 477, doi. 10.1002/mus.28043
- By:
- Publication type:
- Article
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
- Published in:
- Nature Medicine, 2011, v. 17, n. 12, p. 1652, doi. 10.1038/nm.2579
- By:
- Publication type:
- Article
Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097803
- By:
- Publication type:
- Article
Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061177
- By:
- Publication type:
- Article
A High-Density Genome-Wide Association Screen of Sporadic ALS in US Veterans.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0032768
- By:
- Publication type:
- Article
Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes.
- Published in:
- Muscle & Nerve, 2022, v. 66, n. 2, p. 136, doi. 10.1002/mus.27569
- By:
- Publication type:
- Article
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses.
- Published in:
- Muscle & Nerve, 2022, v. 66, n. 1, p. 39, doi. 10.1002/mus.27511
- By:
- Publication type:
- Article
A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2022, v. 65, n. 3, p. 291, doi. 10.1002/mus.27472
- By:
- Publication type:
- Article
Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollment.
- Published in:
- Muscle & Nerve, 2021, v. 64, n. 5, p. 532, doi. 10.1002/mus.27392
- By:
- Publication type:
- Article
Tocilizumab is safe and tolerable and reduces C‐reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients.
- Published in:
- Muscle & Nerve, 2021, v. 64, n. 3, p. 309, doi. 10.1002/mus.27339
- By:
- Publication type:
- Article
Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Developing multidisciplinary clinics for neuromuscular care and research.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Fixed dynamometry is more sensitive than vital capacity or ALS rating scale.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Reply.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2015, v. 52, n. 3, p. 339, doi. 10.1002/mus.24688
- By:
- Publication type:
- Article
7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2013, v. 47, n. 5, p. 760, doi. 10.1002/mus.23720
- By:
- Publication type:
- Article
Developing normalized strength scores for neuromuscular research.
- Published in:
- Muscle & Nerve, 2013, v. 47, n. 2, p. 177, doi. 10.1002/mus.23516
- By:
- Publication type:
- Article
What does body mass index measure in amyotrophic lateral sclerosis and why should we care?
- Published in:
- Muscle & Nerve, 2012, v. 45, n. 4, p. 612, doi. 10.1002/mus.22338
- By:
- Publication type:
- Article
Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials.
- Published in:
- Muscle & Nerve, 2012, v. 45, n. 1, p. 81, doi. 10.1002/mus.22253
- By:
- Publication type:
- Article
Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2011, v. 44, n. 1, p. 20, doi. 10.1002/mus.22114
- By:
- Publication type:
- Article
Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.
- Published in:
- Muscle & Nerve, 2010, v. 42, n. 1, p. 104, doi. 10.1002/mus.21683
- By:
- Publication type:
- Article
Lyme disease serology in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2009, v. 40, n. 4, p. 626, doi. 10.1002/mus.21438
- By:
- Publication type:
- Article
Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2008, v. 38, n. 1, p. 837, doi. 10.1002/mus.21059
- By:
- Publication type:
- Article
Comparison of incremental with multipoint MUNE methods in transgenic ALS mice.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Cerebrospinal fluid levels of F<sub>2</sub>-isoprostanes in patients with neurodegenerative diseases.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 2, p. 165, doi. 10.1016/S0009-9236(99)80190-8
- By:
- Publication type:
- Article
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.914017
- By:
- Publication type:
- Article
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 12, p. 1334, doi. 10.1001/jamaneurol.2023.3711
- By:
- Publication type:
- Article
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 12, p. 1312, doi. 10.1001/jamaneurol.2022.3282
- By:
- Publication type:
- Article
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke–Supported Network for Excellence in Neuroscience Clinical Trials.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 6, p. 755, doi. 10.1001/jamaneurol.2020.0367
- By:
- Publication type:
- Article
The Role of Environmental Toxins in Amyotrophic Lateral Sclerosis Risk.
- Published in:
- JAMA Neurology, 2016, v. 73, n. 7, p. 779, doi. 10.1001/jamaneurol.2016.1038
- By:
- Publication type:
- Article
Cortical Hyperexcitability in Amyotrophic Lateral Sclerosis.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 11, p. 1235, doi. 10.1001/jamaneurol.2015.2197
- By:
- Publication type:
- Article
Cromolyn sodium delays disease onset and is neuroprotective in the SOD1<sup>G93A</sup> Mouse Model of amyotrophic lateral sclerosis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-53982-w
- By:
- Publication type:
- Article
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 12, p. 2297, doi. 10.1002/acn3.51915
- By:
- Publication type:
- Article
A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 1, p. 50, doi. 10.1002/acn3.51491
- By:
- Publication type:
- Article
Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 12, p. 1522, doi. 10.1002/acn3.671
- By:
- Publication type:
- Article
Long‐term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 6, p. 730, doi. 10.1002/acn3.567
- By:
- Publication type:
- Article
Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post‐mortem motor cortex and cerebrospinal fluid.
- Published in:
- Brain Pathology, 2022, v. 32, n. 2, p. 1, doi. 10.1111/bpa.13035
- By:
- Publication type:
- Article
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis.
- Published in:
- Annals of Neurology, 2023, v. 94, n. 3, p. 547, doi. 10.1002/ana.26714
- By:
- Publication type:
- Article
Antibody Response to HML‐2 May Be Protective in Amyotrophic Lateral Sclerosis.
- Published in:
- Annals of Neurology, 2022, v. 92, n. 5, p. 782, doi. 10.1002/ana.26466
- By:
- Publication type:
- Article
Regulatory Approval in ALS; When Is a Single Study Enough?
- Published in:
- Annals of Neurology, 2022, v. 91, n. 6, p. 737, doi. 10.1002/ana.26371
- By:
- Publication type:
- Article
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development.
- Published in:
- Annals of Neurology, 2022, v. 91, n. 2, p. 165, doi. 10.1002/ana.26285
- By:
- Publication type:
- Article
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.
- Published in:
- 2019
- By:
- Publication type:
- journal article